January 9, 2017 / 5:00 AM / 6 months ago

BUZZ-India's Aurobindo Pharma up; U.S. FDA okays firm's generic treatment for seizures

1 Min Read

** Shares of Aurobindo Pharma up as much as 4.32 pct, its highest since Dec 12

** The U.S. FDA approved company's generic treatment, Levetiracetam in Sodium Chloride Injection, for partial onset seizures in adults, the firm said on Saturday - exchange filing bit.ly/2ity3ib

** Company's European subsidiary signs binding agreement to acquire Generis Farmaceutica in Portugal - exchange filing bit.ly/2i8Dplg

** Stock posts biggest intraday pct gain since Nov 25

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below